For help on how to get the results you want, see our search tips.
1655 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Imbruvica (updated)
Ibrutinib, Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 21/10/2014, Revision: 26, Authorised, Last updated: 18/08/2022 -
List item
Human medicine European public assessment report (EPAR): Pergoveris (updated)
follitropin alfa, lutropin alfa, Infertility, Female
Date of authorisation: 25/06/2007, Revision: 14, Authorised, Last updated: 17/08/2022 -
List item
Human medicine European public assessment report (EPAR): Dynastat (updated)
parecoxib sodium, Pain, Postoperative
Date of authorisation: 22/03/2002, Revision: 32, Authorised, Last updated: 17/08/2022 -
List item
Human medicine European public assessment report (EPAR): Ciambra (updated)
pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 02/12/2015,
, Revision: 6, Authorised, Last updated: 17/08/2022
-
List item
Human medicine European public assessment report (EPAR): Orgovyx (updated)
relugolix, Prostatic Neoplasms
Date of authorisation: 29/04/2022,
, Revision: 4, Authorised, Last updated: 17/08/2022
-
List item
Human medicine European public assessment report (EPAR): Prezista (updated)
darunavir, HIV Infections
Date of authorisation: 11/02/2007, Revision: 53, Authorised, Last updated: 17/08/2022 -
List item
Human medicine European public assessment report (EPAR): Duloxetine Zentiva (updated)
duloxetine, Neuralgia; Depressive Disorder, Major; Anxiety Disorders; Diabetes Mellitus
Date of authorisation: 20/08/2015,, Revision: 11, Authorised, Last updated: 16/08/2022
-
List item
Human medicine European public assessment report (EPAR): Zynquista (updated)
Sotagliflozin, Diabetes Mellitus, Type 1
Date of authorisation: 26/04/2019,, Revision: 3, Withdrawn, Last updated: 16/08/2022
-
List item
Human medicine European public assessment report (EPAR): Lokelma (updated)
sodium zirconium cyclosilicate, Hyperkalemia
Date of authorisation: 22/03/2018,, Revision: 6, Authorised, Last updated: 16/08/2022
-
List item
Human medicine European public assessment report (EPAR): Brineura (updated)
cerliponase alfa, Neuronal Ceroid-Lipofuscinoses
Date of authorisation: 30/05/2017,, 
, 
, 
, Revision: 6, Authorised, Last updated: 16/08/2022
-
List item
Human medicine European public assessment report (EPAR): Relvar Ellipta (updated)
fluticasone furoate, vilanterol, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 13/11/2013, Revision: 22, Authorised, Last updated: 16/08/2022 -
List item
Human medicine European public assessment report (EPAR): HBVaxPro (updated)
hepatitis B, recombinant surface antigen, Hepatitis B; Immunization
Date of authorisation: 27/04/2001, Revision: 32, Authorised, Last updated: 16/08/2022 -
List item
Human medicine European public assessment report (EPAR): RotaTeq (updated)
rotavirus serotype G1, serotype G2, serotype G3, serotype G4, serotype P1, Immunization; Rotavirus Infections
Date of authorisation: 26/06/2006, Revision: 34, Authorised, Last updated: 16/08/2022 -
List item
Human medicine European public assessment report (EPAR): Exviera (updated)
dasabuvir sodium, Hepatitis C, Chronic
Date of authorisation: 14/01/2015,, Revision: 25, Authorised, Last updated: 12/08/2022
-
List item
Human medicine European public assessment report (EPAR): Viekirax (updated)
Ombitasvir, paritaprevir, ritonavir, Hepatitis C, Chronic
Date of authorisation: 14/01/2015, Revision: 27, Authorised, Last updated: 12/08/2022 -
List item
Human medicine European public assessment report (EPAR): Sifrol (updated)
pramipexole dihydrochloride monohydrate, Restless Legs Syndrome; Parkinson Disease
Date of authorisation: 13/10/1997, Revision: 36, Authorised, Last updated: 12/08/2022 -
List item
Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (updated)
ChAdOx1-SARS-COV-2, COVID-19 virus infection
Date of authorisation: 29/01/2021,
, , 
, Revision: 23, Authorised, Last updated: 12/08/2022
-
List item
Human medicine European public assessment report (EPAR): Mirapexin (updated)
pramipexole dihydrochloride monohydrate, Restless Legs Syndrome; Parkinson Disease
Date of authorisation: 23/02/1998, Revision: 39, Authorised, Last updated: 12/08/2022 -
List item
Human medicine European public assessment report (EPAR): Veklury (updated)
remdesivir, Coronavirus Infections
Date of authorisation: 03/07/2020,, Revision: 12, Authorised, Last updated: 12/08/2022
-
List item
Human medicine European public assessment report (EPAR): Alecensa (updated)
alectinib hydrochloride, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 16/02/2017,, Revision: 12, Authorised, Last updated: 11/08/2022
-
List item
Human medicine European public assessment report (EPAR): Ranexa (previously Latixa) (updated)
ranolazine, Angina Pectoris
Date of authorisation: 08/07/2008, Revision: 22, Authorised, Last updated: 11/08/2022 -
List item
Human medicine European public assessment report (EPAR): Grasustek (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 20/06/2019,, 
, Revision: 3, Authorised, Last updated: 10/08/2022
-
List item
Human medicine European public assessment report (EPAR): Vaxelis (updated)
Diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae Types 2 and 3, hepatitis B surface antigen produced in yeast cells, poliovirus (inactivated): type 1 (Mahoney), type 2 (MEF-1), type 3 (Saukett) produced in Vero cells/ Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to meningococcal protein., Meningitis, Haemophilus; Poliomyelitis; Tetanus; Diphtheria; Whooping Cough; Hepatitis B
Date of authorisation: 15/02/2016, Revision: 11, Authorised, Last updated: 10/08/2022 -
List item
Human medicine European public assessment report (EPAR): Metalyse (updated)
tenecteplase, Myocardial Infarction
Date of authorisation: 23/02/2001, Revision: 20, Authorised, Last updated: 10/08/2022 -
List item
Human medicine European public assessment report (EPAR): Gliolan (updated)
5-aminolevulinic acid hydrochloride, Glioma
Date of authorisation: 07/09/2007, Revision: 7, Authorised, Last updated: 10/08/2022